A global scientific strategy to cure hepatitis B

dc.contributor.authorRevill, Peter A.
dc.contributor.authorChisari, Francis V.
dc.contributor.authorBlock, Joan M.
dc.contributor.authorDandri, Maura
dc.contributor.authorGehring, Adam J.
dc.contributor.authorGuo, Haitao
dc.contributor.authorHu, Jianming
dc.contributor.authorKramvis, Anna
dc.contributor.authorLampertico, Pietro
dc.contributor.authorJanssen, Harry L. A.
dc.contributor.authorLevrero, Massimo
dc.contributor.authorLi, Wenhui
dc.contributor.authorLiang, T. Jake
dc.contributor.authorLim, Seng-Gee
dc.contributor.authorLu, Fengmin
dc.contributor.authorPenicaud, M. Capucine
dc.contributor.authorTavis, John E.
dc.contributor.authorThimme, Robert
dc.contributor.authorZoulim, Fabien
dc.contributor.departmentMicrobiology and Immunology, School of Medicineen_US
dc.date.accessioned2019-12-20T20:53:12Z
dc.date.available2019-12-20T20:53:12Z
dc.date.issued2019-07
dc.description.abstractChronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationRevill, P. A., Chisari, F. V., Block, J. M., Dandri, M., Gehring, A. J., Guo, H., … Zoulim, F. (2019). A global scientific strategy to cure hepatitis B. The lancet. Gastroenterology & hepatology, 4(7), 545–558. doi:10.1016/S2468-1253(19)30119-0en_US
dc.identifier.urihttps://hdl.handle.net/1805/21533
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/S2468-1253(19)30119-0en_US
dc.relation.journalThe Lancet: Gastroenterology & hepatology,en_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectChronic hepatitis B virus (HBV) infectionsen_US
dc.subjectInternational Coalition to Eliminate HBV (ICE-HBV)en_US
dc.subjectHBV curesen_US
dc.subjectHBV researchen_US
dc.subjectHBV cure research agendasen_US
dc.titleA global scientific strategy to cure hepatitis Ben_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1043026.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: